Professor | Tao Zhu | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Tao Zhu
Contact Information	zhut@ustc.edu.cn
Language ability	English, Chinese
Province	Anhui

Upload Avatar (500 x 500)

Name

Tao Zhu

Contact Information

zhut@ustc.edu.cn

Language ability

English, Chinese

Province

Anhui

University/Lab Affiliation and Title	University of Science and Technology of China
Faculty	Basic Medical Sciences
Academic Background & Achievements	Bachelor's Degree in Medicine: Wuhan University PhD in Science: National University of Singapore Postdoctoral Research: Johns Hopkins University Published over 110 SCI papers, with over 6000 citations and an h-index of 46
Work Experience	Current - University of Science and Technology of China - Professor Current - National Research Center for Microscale Material Science - PI Current - Anhui Provincial Hospital - Joint Professor
Awards	Awarded by the Endocrine Society of America Awarded by the Susan G. Komen Cancer Foundation Supported by the French Innovation Talent Program Supported by the Wuhan High-tech Zone '3551' Talent Program

University/Lab Affiliation and Title

University of Science and Technology of China

Faculty

Basic Medical Sciences

Academic Background & Achievements

Bachelor's Degree in Medicine: Wuhan University
PhD in Science: National University of Singapore
Postdoctoral Research: Johns Hopkins University
Published over 110 SCI papers, with over 6000 citations and an h-index of 46

Work Experience

Current - University of Science and Technology of China - Professor
Current - National Research Center for Microscale Material Science - PI
Current - Anhui Provincial Hospital - Joint Professor

Awards

Awarded by the Endocrine Society of America
Awarded by the Susan G. Komen Cancer Foundation
Supported by the French Innovation Talent Program
Supported by the Wuhan High-tech Zone '3551' Talent Program

Areas of Focus	Tumor Precision Medicine Related Molecular Diagnosis and Treatment Biological Effects of Nanomaterials
Publications	Cancer Stem Cell Regulated Phenotypic Plasticity Protects Metastasizing Tumor Cells from Ferroptosis, Wu M, Zhang X, Chiou YS, Qian W, Liu X, Zhang M, Yan H, Li S, Li T, Han X, Qian P, Liu S, Pan Y, Wu Z, Lobie PE, Zhu T, 2021 Analysis of the oestrogen receptor-associated lncRNA landscape identifies a role for ERLC1 in breast cancer therapy, Yuan H, Yan L, Wu M, Shang Y, Guo Q, Zhang X, Zhu Y, Wu Z, Lobie PE, Zhu T, 2021 Long-term pulmonary pre-exposure to multi-walled carbon nanotubes promotes breast cancer metastatic cascades, Lu X, Zhu Y, Bai R, Wu Z, Qian W, Yang L, Pandey V, Liu Y, Lobie PE, Chen C, Zhu T, 2019 Loss of Estrogen Regulated MIR135A1 at 3p21.1 Promotes Tamoxifen Resistance in Breast Cancer Cells, Zhang W, Wu M, Kang Y, Chong QY, Zhang M, Qian W, Zhang X, Hu L, Zhong Y, Qian P, Kong X, Li G, Ding K, Lobie PE, Zhu T, 2018 CCAR1 5'UTR as a natural miRancer of miR-1254 overrides tamoxifen resistance, Li G, Wu X, Qian W, Wu ZS, Cai H, Sun X, Zhang W, Tan S, Qian P, Ding K, Lu X, Zhang X, Yan H, Song H, Huang S, Wu Q, Lobie PE, Shan G, Zhu T, 2016 Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell specific inhibitor, Liu Y, Chen C, Qian P, Lu X, Sun B, Zhang X, Wang L, Gao X, Li H, Chen Z, Tang J, Zhang W, Dong J, Bai R, Lobie PE, Wu Q, Liu S, Zhang H, Zhao F, Wicha MS, Zhu T, Zhao Y, 2015 Nanotoxicity: A growing need for study in the endocrine system, Lu X, Liu Y, Kong X, Lobie PE, Chen C, Zhu T, 2013 HOXB7 renders breast cancer resistant to tamoxifen through activation of the EGFR Pathway, Jin K, Kong X, Shah T, Penet MF, Wildes F, Sgroi DC, Ma XJ, Huang Y, Kallioniemi A, Landberg G, Bieche I, Lobie PE, Davidson NE, Zaver M, Bhujwalla ZM, Zhu T, Sukumar S, 2012 Loss of SNAIL regulated miR-128-2 on chromosome 3p22.3 promotes mammary epithelial cell oncogenic transformation via targeting multiple stem cell factors, Qian PX, Banerjee A, Wu ZS, Zhang X, Wang H, Pandey V, Zhang WJ, Lu XF, Tan S, Lobie PE, Zhu T, 2012 Pivotal Role of Reduced let-7g Expression in Breast Cancer Invasion and Metastasis, Qian P, Zuo Z, Wu Z, Meng X, Li G, Wu Z, Zhang W, Tan S, Pandey V, Yao Y, Wang P, Zhao L, Wang J, Wu Q, Song E, Lobie PE, Yin Z, Zhu T, 2011

Areas of Focus

Tumor Precision Medicine Related Molecular Diagnosis and Treatment
Biological Effects of Nanomaterials

Publications

Cancer Stem Cell Regulated Phenotypic Plasticity Protects Metastasizing Tumor Cells from Ferroptosis, Wu M, Zhang X, Chiou YS, Qian W, Liu X, Zhang M, Yan H, Li S, Li T, Han X, Qian P, Liu S, Pan Y, Wu Z, Lobie PE, Zhu T, 2021
Analysis of the oestrogen receptor-associated lncRNA landscape identifies a role for ERLC1 in breast cancer therapy, Yuan H, Yan L, Wu M, Shang Y, Guo Q, Zhang X, Zhu Y, Wu Z, Lobie PE, Zhu T, 2021
Long-term pulmonary pre-exposure to multi-walled carbon nanotubes promotes breast cancer metastatic cascades, Lu X, Zhu Y, Bai R, Wu Z, Qian W, Yang L, Pandey V, Liu Y, Lobie PE, Chen C, Zhu T, 2019
Loss of Estrogen Regulated MIR135A1 at 3p21.1 Promotes Tamoxifen Resistance in Breast Cancer Cells, Zhang W, Wu M, Kang Y, Chong QY, Zhang M, Qian W, Zhang X, Hu L, Zhong Y, Qian P, Kong X, Li G, Ding K, Lobie PE, Zhu T, 2018
CCAR1 5'UTR as a natural miRancer of miR-1254 overrides tamoxifen resistance, Li G, Wu X, Qian W, Wu ZS, Cai H, Sun X, Zhang W, Tan S, Qian P, Ding K, Lu X, Zhang X, Yan H, Song H, Huang S, Wu Q, Lobie PE, Shan G, Zhu T, 2016
Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell specific inhibitor, Liu Y, Chen C, Qian P, Lu X, Sun B, Zhang X, Wang L, Gao X, Li H, Chen Z, Tang J, Zhang W, Dong J, Bai R, Lobie PE, Wu Q, Liu S, Zhang H, Zhao F, Wicha MS, Zhu T, Zhao Y, 2015
Nanotoxicity: A growing need for study in the endocrine system, Lu X, Liu Y, Kong X, Lobie PE, Chen C, Zhu T, 2013
HOXB7 renders breast cancer resistant to tamoxifen through activation of the EGFR Pathway, Jin K, Kong X, Shah T, Penet MF, Wildes F, Sgroi DC, Ma XJ, Huang Y, Kallioniemi A, Landberg G, Bieche I, Lobie PE, Davidson NE, Zaver M, Bhujwalla ZM, Zhu T, Sukumar S, 2012
Loss of SNAIL regulated miR-128-2 on chromosome 3p22.3 promotes mammary epithelial cell oncogenic transformation via targeting multiple stem cell factors, Qian PX, Banerjee A, Wu ZS, Zhang X, Wang H, Pandey V, Zhang WJ, Lu XF, Tan S, Lobie PE, Zhu T, 2012
Pivotal Role of Reduced let-7g Expression in Breast Cancer Invasion and Metastasis, Qian P, Zuo Z, Wu Z, Meng X, Li G, Wu Z, Zhang W, Tan S, Pandey V, Yao Y, Wang P, Zhao L, Wang J, Wu Q, Song E, Lobie PE, Yin Z, Zhu T, 2011

Tumor Precision Medicine Molecular Diagnosis Treatment Nanomaterials Biological Effects Cancer Research Pathology Translational Medicine

Xiaowei Zhang - Peking University

Ying Zhao - Peking University

Wenhua Yu - Peking University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us